Abstracts - faqs.org

Abstracts

News, opinion and commentary

Search abstracts:
Abstracts » News, opinion and commentary

Your financial future in your hands

Article Abstract:

One's financial planner is in the perfect position to monitor developments most people are unaware of, by keeping abreast of tax breaks, new legislation and market forces, giving one the edge at the time of tax. The Financial Planning Association of Australia has provided with questions to be asked to any financial planner and the tax strategies are mentioned.

Publisher: A C P Computer Publications
Publication Name: The Bulletin with Newsweek
Subject: News, opinion and commentary
ISSN: 1440-7485
Year: 2003
Services information, Financial Planning, Services, Questions and answers, Financial Planning Association

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


All the rage

Article Abstract:

Stephen Sewell, an Australian writer is writing for the past twenty-seven years and some of his best work has resulted from harnessing his anger and channeling it into drama. His most successful plays are outpourings of rage against hypocrisy, cynicism, and political opportunism and one of them is going to be at the Olympic Arts Festival in Athens in 2004.

Author: Prior, Sian
Publisher: A C P Computer Publications
Publication Name: The Bulletin with Newsweek
Subject: News, opinion and commentary
ISSN: 1440-7485
Year: 2003
Appreciation, Works, Authors, Australian, Australian writers, Sewell, Stephen

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: Australia
Similar abstracts:
  • Abstracts: Australiana: Global warming. A life thrice ruined. The Forger
  • Abstracts: The thinning blue line. We're not in the mood
  • Abstracts: Red alert. The battle isn't over
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.